ID
27907
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (3)
- 12/4/17 12/4/17 -
- 12/4/17 12/4/17 -
- 1/4/18 1/4/18 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
December 4, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Laboratory GOAL Trial B-cell Lymphoma NCT02499003
Laboratory GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Description
Laboratory: Hematology
Description
Date
Data type
date
Description
Hematocrit lab value
Data type
text
Description
Hematocrit unit
Data type
text
Description
Hematocrit clinical significance
Data type
boolean
Description
Hematocrit CTCAE
Data type
text
Description
Hemoglobin lab value
Data type
text
Description
Hemoglobin unit
Data type
text
Description
Hemoglobin clinical significance
Data type
boolean
Description
Hemoglobin CTCAE
Data type
text
Description
Red blood cells lab value
Data type
text
Description
Red blood cells unit
Data type
text
Description
Red blood cells clinical significance
Data type
boolean
Description
Red blood cells CTCAE
Data type
text
Description
White blood cells lab value
Data type
text
Description
White blood cells unit
Data type
text
Description
White blood cells clinical significance
Data type
boolean
Description
White blood cells CTCAE
Data type
text
Description
Platelets lab value
Data type
text
Description
Platelets unit
Data type
text
Description
Platelets clinical significance
Data type
boolean
Description
Platelets CTCAE
Data type
text
Description
Neutrophils lab value
Data type
text
Description
Neutrophils unit
Data type
text
Description
Neutrophils clinical significance
Data type
boolean
Description
Neutrophils CTCAE
Data type
text
Description
Eosinophils lab value
Data type
text
Description
Eosinophils unit
Data type
text
Description
Eosinophils clinical significance
Data type
boolean
Description
Eosinophils CTCAE
Data type
text
Description
Basophils lab value
Data type
text
Description
Basophils unit
Data type
text
Description
Basophils clinical significance
Data type
boolean
Description
Basophils CTCAE
Data type
text
Description
Monocytes lab value
Data type
text
Description
Monocytes unit
Data type
text
Description
Monocytes clinical significance
Data type
boolean
Description
Monocytes CTCAE
Data type
text
Description
Lymphocytes lab value
Data type
text
Description
Lymphocytes unit
Data type
text
Description
Lymphocytes clinical significance
Data type
boolean
Description
Lymphocytes CTCAE
Data type
text
Description
ANC lab value
Data type
text
Description
ANC unit
Data type
text
Description
ANC clinical significance
Data type
boolean
Description
ANC CTCAE
Data type
text
Description
Laboratory: Blood chemistry
Description
Sodium lab value
Data type
text
Description
Sodium unit
Data type
text
Description
Sodium clinical significance
Data type
boolean
Description
Sodium CTCAE
Data type
text
Description
Potassium lab value
Data type
text
Description
Potassium unit
Data type
text
Description
Potassium clinical significance
Data type
boolean
Description
Potassium CTCAE
Data type
text
Description
Calcium lab value
Data type
text
Description
Calcium unit
Data type
text
Description
Calcium clinical significance
Data type
boolean
Description
Calcium CTCAE
Data type
text
Description
Chloride lab value
Data type
text
Description
Chloride unit
Data type
text
Description
Chloride clinical significance
Data type
boolean
Description
Chloride CTCAE
Data type
text
Description
Magnesium lab value
Data type
text
Description
Magnesium unit
Data type
text
Description
Magnesium clinical significance
Data type
boolean
Description
Magnesium CTCAE
Data type
text
Description
Bilirubin lab value
Data type
text
Description
Bilirubin unit
Data type
text
Description
Bilirubin clinical significance
Data type
boolean
Description
Bilirubin (total) CTCAE
Data type
text
Description
AST GOT lab value
Data type
text
Description
AST GOT unit
Data type
text
Description
AST GOT clinical significance
Data type
boolean
Description
AST GOT CTCAE
Data type
text
Description
ALT GPT lab value
Data type
text
Description
ALT GPT unit
Data type
text
Description
ALT GPT clinical significance
Data type
boolean
Description
ALT GPT CTCAE
Data type
text
Description
GGT lab value
Data type
text
Description
GGT unit
Data type
text
Description
GGT clinical significance
Data type
boolean
Description
GGT CTCAE
Data type
text
Description
Lipase lab value
Data type
text
Description
Lipase unit
Data type
text
Description
Lipase clinical significance
Data type
boolean
Description
Lipase CTCAE
Data type
text
Description
Amylase lab value
Data type
text
Description
Amylase unit
Data type
text
Description
Amylase clinical significance
Data type
boolean
Description
Amylase CTCAE
Data type
text
Description
Creatinine lab value
Data type
text
Description
Creatinine unit
Data type
text
Description
Creatinine clinical significance
Data type
boolean
Description
Creatinine CTCAE
Data type
text
Description
Uric acid lab value
Data type
text
Description
Uric acid unit
Data type
text
Description
Uric acid clinical significance
Data type
boolean
Description
Uric acid CTCAE
Data type
text
Description
Troponin T or Troponin I
Data type
text
Description
Troponin T or Troponin I
Data type
text
Description
Troponin T or Troponin I
Data type
boolean
Description
Troponin T or Troponin I
Data type
text
Description
Troponin T or Troponin I
Data type
text
Description
Troponin T or Troponin I
Data type
text
Description
Troponin T or Troponin I
Data type
boolean
Description
Troponin T or Troponin I
Data type
text
Description
This item applies to the following visits: Day 1 of Cycles 1 - 6; Day 22 of Cycles 2 - 6; Interim Staging; End of Treatment; Follow Up 1 - 8.
Data type
text
Description
This item applies to the following visits: Day 1 of Cycles 1 - 6; Day 22 of Cycles 2 - 6; Interim Staging; End of Treatment; Follow Up 1 - 8.
Data type
text
Description
This item applies to the following visits: Day 1 of Cycles 1 - 6; Day 22 of Cycles 2 - 6; Interim Staging; End of Treatment; Follow Up 1 - 8.
Data type
boolean
Description
This item applies to the following visits: Day 1 of Cycles 1 - 6; Day 22 of Cycles 2 - 6; Interim Staging; End of Treatment; Follow Up 1 - 8.
Data type
text
Description
BNP or NT-ProBNP. This item applies to the following visits: Days 8, 15, and 22 of Cycle 1; Day 1 of Cycles 2 - 6; Interim Staging; End of Treatment; Follow Up 1 - 8.
Data type
text
Description
BNP or NT-ProBNP. This item applies to the following visits: Days 8, 15, and 22 of Cycle 1; Day 1 of Cycles 2 - 6; Interim Staging; End of Treatment; Follow Up 1 - 8.
Data type
text
Description
BNP or NT-ProBNP. This item applies to the following visits: Days 8, 15, and 22 of Cycle 1; Day 1 of Cycles 2 - 6; Interim Staging; End of Treatment; Follow Up 1 - 8.
Data type
boolean
Description
BNP or NT-ProBNP. This item applies to the following visits: Days 8, 15, and 22 of Cycle 1; Day 1 of Cycles 2 - 6; Interim Staging; End of Treatment; Follow Up 1 - 8.
Data type
text
Description
BNP or NT-ProBNP. This item applies to the following visits: Days 8, 15, and 22 of Cycle 1; Day 1 of Cycles 2 - 6; Interim Staging; End of Treatment; Follow Up 1 - 8.
Data type
text
Description
BNP or NT-ProBNP. This item applies to the following visits: Days 8, 15, and 22 of Cycle 1; Day 1 of Cycles 2 - 6; Interim Staging; End of Treatment; Follow Up 1 - 8.
Data type
text
Description
BNP or NT-ProBNP. This item applies to the following visits: Days 8, 15, and 22 of Cycle 1; Day 1 of Cycles 2 - 6; Interim Staging; End of Treatment; Follow Up 1 - 8.
Data type
boolean
Description
BNP or NT-ProBNP. This item applies to the following visits: Days 8, 15, and 22 of Cycle 1; Day 1 of Cycles 2 - 6; Interim Staging; End of Treatment; Follow Up 1 - 8.
Data type
text
Description
This item applies to the following visits: Cycle 1 Day 1, Interim Staging, and Follow Up 1 - 8.
Data type
text
Description
This item applies to the following visits: Cycle 1 Day 1, Interim Staging, and Follow Up 1 - 8.
Data type
text
Description
This item applies to the following visits: Cycle 1 Day 1, Interim Staging, and Follow Up 1 - 8.
Data type
boolean
Description
This item applies to the following visits: Cycle 1 Day 1, Interim Staging, and Follow Up 1 - 8.
Data type
text
Similar models
Laboratory GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
No comments